MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$189,247K Marketable securities,current$152,670K Prepaid expenses andother current assets$7,800K Total property andequipment, gross$24,255K Total current assets$349,717K Operating leaseright-of-use asset$20,116K Marketable securities,non-current$18,114K Property and equipment,net$5,044K Other assets$3,048K Restricted cash$1,088K Accumulated depreciation$19,211K Total assets$397,127K Total liabilities,redeemable convertible...$397,127K Total stockholders'equity (deficit)$354,966K Total liabilities$42,161K Accumulated deficit-$489,547K Additionalpaid-in-capital$844,354K Total currentliabilities$22,556K Operating leaseliabilities, net of current...$18,511K Other liabilities,non-current$1,094K Accumulated othercomprehensive income$110K Common stock, 0.001 parvalue 500,000,000 and...$49K Accrued expenses andother current...$15,967K Operating leaseliabilities, current$4,795K Accounts payable$1,794K
Balance Sheet
source: myfinsight.com

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics, Inc. (MAZE)